INOVOTION’s Olivier Baverey V.I.E. was recently interviewed by North Shore InnoVentures (NSIV), highlighting the company’s role in accelerating pre-clinical testing for Oncology Drug Discovery. To better serve its US market, INOVOTION has opened a subsidiary in Boston in Feb 2018. Olivier and his colleagues support US-based Biotech/Pharma companies and academic research centers to dramatically improve their preclinical assays in oncology. Many thanks to the “Région Auvergne-Rhône-Alpes” for supporting the participation of Olivier to the V.I.E. program.
Give Olivier a call to learn more about how to dramatically improve your Drug Discovery productivity!
+1 (617) 337-7855 olivier.baverey@inovotion.com
